Shaan C. Gandhi
VP at Pfizer
Cambridge, Massachusetts
Overview
Work Experience
Vice President and Head of Strategic Partnerships, Pfizer Ignite
2023 - Current
Pfizer Ignite is a new end-to-end offering for biotech partners that leverages Pfizer’s resources, scale and expertise to amplify and accelerate innovation from preclinical R&D through the development lifecycle. Learn more at www.pfizerignite.com.
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.
Independent Board Member
2023
1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development.
Raised $26,650,000.00 from Accenture Ventures.
Board Member
2020 - 2023
Acquired by Eli Lilly (NYSE: LLY) August 2023, formerly NASDAQ: DICE
Board Member
2020 - 2023
NASDAQ: VIGL
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Raised $180,000,000.00 from Sanofi.
Board Member
2022 - 2022
NASDAQ: KYTX
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
Raised $170,000,000.00 from Northpond Ventures, Gilead Sciences, CAM Capital, Westlake Village BioPartners, LYFE Capital, Insight Partners, Bain Capital Life Sciences, RTW Investments, Vida Ventures and GordonMD Global Investments.
Board Member
2022 - 2022
Transition Bio provides condensate technology for drug discovery and diagnostics.
Raised $63,265,426.00 from Bristol-Myers Squibb, Northpond Ventures, Taiho Ventures, Magnetic Ventures and Lifeforce Capital.
Board Member
2021 - 2022
StrideBio is a gene therapy company that develops genetic medicines with curative potential for patients with devastating conditions.
Raised $97,200,000.00 from Northpond Ventures, CaaS Capital Management, Takeda Ventures, Sarepta Therapeutics, Alexandria Venture Investments, Novo Holdings, UCB Ventures, UF Innovate Ventures, Pontifax and Octagon Capital Advisors.
Board Member
2021 - 2022
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Raised $190,000,000.00 from The Kraft Group, Enavate Sciences, Andreessen Horowitz, Gaingels, Polaris Partners, Northpond Ventures and 5AM Ventures.
Board Member
2021 - 2022
Board Member
2021 - 2022
Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases.
Raised $134,000,000.00 from Northpond Ventures, Alexandria Venture Investments, Sectoral Asset Management, Cormorant Asset Management, OrbiMed, Mass General Brigham Ventures and Aisling Capital.